Literature DB >> 2463224

Desensitization of human basophils with suboptimal concentrations of agonist. Evidence for reversible and irreversible desensitization.

J J Pruzansky1, R Patterson.   

Abstract

Leucocytes from allergic donors were preincubated with suboptimal concentrations of ragweed or anti-IgE and then challenged with increasing concentrations of the homologous or heterologous agonist. The initial incubation resulted in desensitization, as judged by a reduced reactivity relative to controls preincubated without agonist but challenged similarly. Both homologous and heterologous desensitization were observed and were dose dependent. Evidence was obtained for both a reversible and irreversible component of desensitization, which was also agonist-concentration related. Reversibility occurred to a similar degree either by incubation of suboptimally desensitized cells with optimal concentrations of agonist or by removal of IgE and resensitization. This could implicate IgE-agonist aggregation on the basophil surface as a mechanism of desensitization. Histamine release from desensitized cells was highly correlated with degranulation, suggesting that individual cells were desensitized in an all-or-none manner.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2463224      PMCID: PMC1385485     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  7 in total

1.  Significance of concordant fluctuation and loss of leukocyte sensitivity to two allergens during injection therapy with one nonspecific desensitization.

Authors:  C D May; M J Schumacher; C S Williams
Journal:  J Allergy Clin Immunol       Date:  1972-08       Impact factor: 10.793

2.  The immediate allergic response: in vitro separation of antigen activation, decay and histamine release.

Authors:  L M Lichtenstein
Journal:  J Immunol       Date:  1971-10       Impact factor: 5.422

3.  An automated continuous-flow system for the extraction and fluorometric analysis of histamine.

Authors:  R P Siraganian
Journal:  Anal Biochem       Date:  1974-02       Impact factor: 3.365

4.  Studies of antigen binding on human basophils. II. Continued expression of antigen-specific IgE during antigen-induced desensitization.

Authors:  D MacGlashan; M Mogowski; L M Lichtenstein
Journal:  J Immunol       Date:  1983-05       Impact factor: 5.422

5.  Subthreshold and suboptimal desensitization human basophils. I. Kinetics of decay of releasability.

Authors:  G R Mendoza; K Minagawa
Journal:  Int Arch Allergy Appl Immunol       Date:  1982

6.  Basophil counting with a new staining method using alcian blue.

Authors:  H S Gilbert; L Ornstein
Journal:  Blood       Date:  1975-08       Impact factor: 22.113

7.  Limiting concentrations of human basophil-bound IgE antibody required for histamine release.

Authors:  J J Pruzansky; R Patterson
Journal:  Immunology       Date:  1988-06       Impact factor: 7.397

  7 in total
  6 in total

1.  In vitro desensitization of human skin mast cells.

Authors:  Wei Zhao; Gregorio Gomez; Matthew Macey; Christopher L Kepley; Lawrence B Schwartz
Journal:  J Clin Immunol       Date:  2011-10-19       Impact factor: 8.317

2.  Polymerization of actin does not regulate desensitization in human basophils.

Authors:  Donald MacGlashan; Natalia Vilariño
Journal:  J Leukoc Biol       Date:  2009-01-15       Impact factor: 4.962

Review 3.  Pros and Cons of Clinical Basophil Testing (BAT).

Authors:  Hans Jürgen Hoffmann; Edward F Knol; Martha Ferrer; Lina Mayorga; Vito Sabato; Alexandra F Santos; Bernadette Eberlein; Anna Nopp; Donald MacGlashan
Journal:  Curr Allergy Asthma Rep       Date:  2016-07       Impact factor: 4.806

4.  Timescale Separation of Positive and Negative Signaling Creates History-Dependent Responses to IgE Receptor Stimulation.

Authors:  Brooke Harmon; Lily A Chylek; Yanli Liu; Eshan D Mitra; Avanika Mahajan; Edwin A Saada; Benjamin R Schudel; David A Holowka; Barbara A Baird; Bridget S Wilson; William S Hlavacek; Anup K Singh
Journal:  Sci Rep       Date:  2017-11-14       Impact factor: 4.379

5.  Case Report: Maintenance of Desensitization to Nebulized Colomycin Over 10 Years.

Authors:  Justyna Sieber; Sabine Renner; Andrea Lakatos-Krepcik; Zsolt Szépfalusi
Journal:  Front Pediatr       Date:  2021-04-01       Impact factor: 3.418

Review 6.  Hypersensitivity reactions to monoclonal antibodies: Classification and treatment approach (Review).

Authors:  Irena Pintea; Carina Petricau; Dinu Dumitrascu; Adriana Muntean; Daniel Constantin Branisteanu; Daciana Elena Branisteanu; Diana Deleanu
Journal:  Exp Ther Med       Date:  2021-07-03       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.